MedTrace Logo

Retrospective Observational Study of Implant-supported Restorations With Dental Implants.

NCT06154057 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-03-12

No results posted yet for this study

Summary

This retrospective study aims to value the bone loss and the success and survival of the dental implants produced by additive manufacturing installed in an area grafted with Plenum® Osshp (synthetic bone graft). In addition, the biological and biomechanical performance of implant restorations supported through an observational retrospective solution will be observed. From 50 to 100 survey participants will be selected, who will be invited to attend the clinic for clinical, radiographic, and prosthetic evaluation and successful parameters between baseline, 3, 6, and 12 months. The data obtained regarding bone loss (primary outcome) of the analyzed regions and implant success and survival in area grafted with Plenum® Osshp (secondary outcome) will be evaluated by the paired t-test for the evaluation of the times (3, 6, and 12 months) and survival curves of the installed dental implants.

Conditions

  • Oral Surgical Procedures

Interventions

PROCEDURE

Dental Implants installed in an grafted area (sinus lifting)

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

PROCEDURE

Dental Implants installed in an grafted area (ridge augmentation)

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

PROCEDURE

Dental Implants installed in an grafted area (extraction sites)

The patient will be invited to participate in the clinic to assess radiographic bone loss and clinical follow-up for 12 months.

Sponsors & Collaborators

  • University of Guarulhos

    collaborator OTHER

  • M3 Health

    lead INDUSTRY

Principal Investigators

  • Jamil A Shibli, PhD · University of Guarulhos, UnG

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-07-30
Completion
2024-07-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06154057 on ClinicalTrials.gov